Azithromycin/Dexamethasone

阿奇霉素/地塞米松

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAzithromycin/Dexamethasone
Drug Alias Name地塞米松/阿奇霉素Dexamethasone/AzithromycinAzithromycin and DexamethasoneDexamethasone and AzithromycinISV-502 +[6] 
ClassificationSmall molecules > SteroidsSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionGlucocorticoid receptor agonists50S ribosomal subunit inhibitors
Targets50S ribosomal subunitGlucocorticoid receptor
Therapy Area/IndicationsBlepharitisConjunctivitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes DexamethasoneAzithromycin
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSun Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAkornSun Pharmaceutical Industries Ltd
Active IndicationsN/A
Inactive IndicationsBlepharitisConjunctivitis

Other Information

ATC CodeN/A
Related LinksN/A